We observed no significant difference between the treatment group and the control group in the frequency of the composite primary perinatal outcome (32.4% and 37.0%, respectively; relative risk, 0.87; 97% confidence interval [CI], 0.72 to 1.07; P = 0.14) (Table 2).
There were no perinatal deaths in either group.